PLoS ONE (Jan 2023)

Feasibility of a patient-oriented navigation programme for patients with lung cancer or stroke in Germany: Protocol of the CoreNAVI study.

  • Kathrin Gödde,
  • Hella Fügemann,
  • Ute Goerling,
  • Ulrike Grittner,
  • Raphael Kohl,
  • Andreas Meisel,
  • Thomas Reinhold,
  • Susanne Schnitzer,
  • P Markus Deckert,
  • Nikolaj Frost,
  • Stephan J Schreiber,
  • Nina Rieckmann,
  • Christine Holmberg

DOI
https://doi.org/10.1371/journal.pone.0287638
Journal volume & issue
Vol. 18, no. 6
p. e0287638

Abstract

Read online

BackgroundPatient navigation programmes were introduced in the United States and recently gained interest in Germany, where the health care system is fragmented. Navigation programmes aim to decrease barriers to care for patients with age-associated diseases and complex care paths. Here we describe a feasibility study to evaluate a patient-oriented navigation model that was developed in a first project phase by integrating data about barriers to care, vulnerable patient populations and existing support services.MethodsWe designed a mixed-methods feasibility study that consists of two two-arm randomized controlled trials aligned with observational cohorts. The intervention group of the RCTs gets support by personal navigators for 12 months. The control group receives a brochure with regional support offers for patients and caregivers. The feasibility of the patient-oriented navigation model for two prototypic age-associated diseases, lung cancer and stroke, is evaluated with regard to its acceptance, demand, practicality and efficacy. This investigation includes process evaluation measures with detailed documentation of the screening and recruitment process, questionnaires about satisfaction with navigation, observant participation and qualitative interviews. Estimates of efficacy for patient-reported outcomes are obtained at three follow-up time points including satisfaction with care and health-related quality of life. Furthermore, we analyze health insurance data from patients of the RCT insured at a large German health insurance (AOK Nordost) to investigate heath care utilization, costs and cost effectiveness.Trial registrationThe study is registered at the German Clinical Trial Register (DRKS-ID: DRKS00025476).